BRCA1 and breast carcinoma: We applied the same analyses described above to results from the Milne et al. GWAS of ER-negative breast cancer, which included data on 21,468 cases and 100,594 controls, combined with 18,908 BRCA1 mutation carriers (9414 with breast cancer)3.